Zheng, J. and Wang, E. (2026) “Review of the CRISPR/Cas9 System on the Development of Novel Cancer-Focused Diagnostics and Therapies”, Berkeley Pharma Tech Journal of Medicine, 6(1), pp. 58–79. doi: 10.52243/bptjm.v6i1.77.